Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 2,126,959 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 2,126,959 · Balance 2,126,959 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 2,126,959 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013223 · section16.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,126,959 Underlying: Common · 2,126,959 shares Expires 2035-11-16 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 34,725 | $0.07 | $2,465.48 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 6 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,714,005 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 4,265 | $0.07 | $298.55 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,679,280 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 731,368 | $0.07 | $49,733.02 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 4 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,675,015 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 68,000 | $0.07 | $4,556.00 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 3 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 943,647 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,647 | $0.07 | $7,045.29 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 2 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 875,647 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 500,000 | $0.06 | $32,000.00 |
DisclosureSEC source: 0001654954-25-002968 · section16.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 775,000 Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 34,725 | $0.07 | $2,465.48 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 6 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 2,378,485 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 4,265 | $0.07 | $298.55 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 2,343,760 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 731,368 | $0.07 | $49,733.02 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 4 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 2,399,495 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 68,000 | $0.07 | $4,556.00 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 3 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,608,127 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,647 | $0.07 | $7,045.29 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 2 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,540,127 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| March 17, 2025 Filed Mar 27, 2025 13:56 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 500,000 | $0.06 | $32,000.00 |
DisclosureSEC source: 0001654954-25-003382 · section16.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Jeffrey M. Rowe Living Trust Disclosed balance after: 1,439,480 F1 · balance_after: Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:13 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Appreciation Rights · Derivative | 2,126,959 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014271 · section16.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,126,959 Underlying: Common · 2,126,959 shares Expires 2034-11-10 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 1,465,727 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016441 · section16.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,727 Underlying: Common Stock · 1,465,727 shares Expires 2032-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| May 12, 2021 Filed May 13, 2021 14:54 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001171843-21-003480 · ownership.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Shares, without par value · 1,000,000 shares Expires 2031-05-12 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 31, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001787 · ownership.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares, without par value · 250,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:11 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000262 · ownership.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Shares, without par value · 350,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 22:48 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000960 · rowe-zomed_fm4nov292018.xml · derivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 175,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 22:48 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 175,000 | $1.20 | $210,000.00 |
DisclosureSEC source: 0000905718-18-000960 · rowe-zomed_fm4nov292018.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:53 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000334 · zomedica_form4mar232018.xml · derivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 100,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:53 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 100,000 | $0.20 | $20,000.00 |
DisclosureSEC source: 0000905718-18-000334 · zomedica_form4mar232018.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.